HIGH-THROUGHPUT SCREENING AND DYNAMIC STUDIES OF SELECTED COMPOUNDS AGAINST SARS-COV-2
نویسندگان
چکیده
Objective: This study was aimed to analyze the inhibitory effect of drugs used in nanocarrier as well nanoparticles formulation based drug delivery system selected from PubChem database literature against 3CLpro (3C-like protease) receptor SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) by implementing several silico analysis techniques. Methods: paper detailed a molecular docking-based virtual screening 5240 compounds previously utilized nanoparticle and systems utilizing AutoDock Vina software on 3CL protease discover potential inhibitors using docking technique. Results: According results screening, top two compounds, Id 58823276 60838 exhibited high affinity for binding region. Their affinities were-9.6 and-8.5 kJ/mol, indicating that they were tightly bound target receptor, respectively. These outperformed those obtained co-crystallized native ligand, which of-7.4 kJ/mol. 60838, main hit compound terms both ADMET analysis, displayed substantial deformability after MD simulation. As result VS techniques, novel discovered Lipinski rule five functional contacts with protein, evidenced findings this work. Conclusion: The suggest may represent attractive opportunities development COVID-19 need further evaluation investigation.
منابع مشابه
Designing an ELISA Method for Measurement of Human IgG and IgM Antibodies against SARS-CoV-2
Background and purpose: Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, an indirect ELISA method was designed to measure the human IgM and IgG antibodies against SARS-CoV-2. Materials and methods: Protein sequence of nucleocapsid antigen from SARS-CoV-2 was expressed in E. coli BL21 and then was...
متن کاملSARS-CoV-2 and its dynamic impact on emergency department preparedness and management
Introduction: Emerging viral diseases (EVDs) pose a significant threat to public health. There have been a few viral epidemics in the last two decades. Coronavirus disease 2019 (COVID-19) is now a global pandemic.Objective: To provide emergency physicians an update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its dynamic impact on the emergency department (ED) in te...
متن کاملChloroquine/Hydroxychloroquine AND SARS-CoV 2; lessons from case-control studies
Chloroquine has several disadvantages consisting hypoglycemia, diarrhea, prolong QTc interval, and AV block (21-22). In addition, Gendelman et al., recently published an article about inefficacy of continuous Hydroxychloroquine or colchicine therapy for prevention of SARS-CoV 2 infection (23). According to recent RCTs, HCQ has no therapeutic effects on prevention or improvment of major outcomes...
متن کاملSARS-CoV-2 infection: its psychiatric manifestations
Background: The clinical presentation of SARS-CoV-2 infection was initially dominated by respiratory symptoms. However the clinical spectrum is wide and neuropsychiatric syndromes are also a source of medical concern. Our aims are to present an atypical clinical presentation of SARS-CoV-2 infection characterized by auditory hallucinations and unusual behavior and to emphasize the diversity of ...
متن کاملAssessment of protection against SARS-CoV-2 infection by measuring antibody titer, yes or no!
Dear Editor The current epidemic of the novel Coronavirus disease 2019 (COVID-19) risen from Wuhan, China, turned into a worldwide concern because of its incubation period (2-14 days) and its high transmission rate. The first cases of the infection were reported in December 2019 in Wuhan with symptoms like pneumonia for an unknown reason. Very soon it was known as a novel kind of Coronavirus o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Applied Pharmaceutics
سال: 2022
ISSN: ['0975-7058']
DOI: https://doi.org/10.22159/ijap.2022v14i1.43105